Postoperative radiotherapy 'not advisable' in advanced NSCLC
Trial findings clarify lack of benefit and increased cardiopulmonary toxicity
AusDoc brings you the latest news from the European Society for Medical Oncology virtual congress 2020.
Postoperative radiotherapy cannot be routinely recommended for patients with completely resected stage III N2 non-small cell lung cancer, researchers say after conducting a randomised controlled trial.
The keenly-awaited results follow a long-running controversy over use of postoperative radiotherapy (PORT) since a 1998 Lancet meta-analysis cast doubt on
